Boehringer Ingelheim strengthens commitments in ASKAN
Biopharmaceutical company Boehringer Ingelheim is strengthening its commitment to positively impact people, animals, communities, and the planet through key sustainability initiatives across ASEAN, South Korea, Australia, New Zealand (ASKAN) and Viet Nam.
Biopharmaceutical company Boehringer Ingelheim is strengthening its commitment to positively impact people, animals, communities, and the planet through key sustainability initiatives across ASEAN, South Korea, Australia, New Zealand (ASKAN) and Viet Nam.
Under the “Sustainable Development – For Generations” framework, the company has globally pledged 250 million euros (US$259.7 million) to combat infectious diseases in humans and animals, expanding healthcare access for non-communicable diseases for 50 million people in vulnerable communities, including in the ASKAN area.
The company also commits to invest 35 billion euros ($36.4 billion) in health innovation to tackle non-communicable diseases.
In addition to improving access to healthcare, the company is committed to carbon neutrality in company operations by 2030 and is taking steps to contribute to food security and safety, building a sustainable and healthy future for all.
Cyndy B. Galimpin, general manager of Boehringer Ingelheim, Vietnam said: “Our mission is to create more value for communities in Viet Nam, foster collaborations with like-minded partners to understand the hard-to-reach and vulnerable groups in Viet Nam and take necessary steps to enhance the quality of life for current and future generations as well as protecting our environment.”
In Viet Nam, Boehringer Ingelheim Vietnam is partnering with 120 local hospitals to improve stroke care.
Boehringer Ingelheim is also working closely with veterinarians, pet owners, and health authorities to help control and prevent the spread of infectious diseases among animals. They have vaccinated close to 6,400 dogs and cats in Long An Province and worked with local partners to build capacity and educate villages and students about the importance of self-protection and pet vaccination.
In other areas of animal healthcare, Boehringer Ingelheim Vietnam has implemented the sampling and diagnosing of 230,000 pigs and 29,400 sows across the country, and organised educational programs to raise public awareness of ileitis prevention and the benefits of reducing antibiotics in animal husbandry. — VNS
